AcCAD; AcPUT; CAD; Cancer diagnostic markers; DAP; DiAcCAD; DiAcPUT; DiAcSPD; DiAcSPM; Liquid chromatography­tandem mass spectrometry; N(1)-(3-aminopropyl)butane-1,4-diamine trihydrochloride; N(1)AcSPD; N(1)AcSPM; N(8)AcSPD; N,N'-((butane-1,4-diylbis(azanediyl))bis(propane-3,1-diyl))diacetamide dihydrochloride; N,N'-(butane-1,4-diyl)diacetamide; N,N'-(pentane-1,5-diyl)diacetamide; N,N'-bis-(3-aminopropyl)butane-1,4-diamine tetrahydrochloride; N-(3-((4-((3-aminopropyl)amino)butyl)amino)propyl)acetamide trihydrochloride; N-(3-((4-acetamidobutyl)amino)propyl)acetamide hydrochloride; N-(3-((4-aminobutyl)amino)propyl)acetamide dihydrochloride; N-(4-((3-aminopropyl)amino)butyl)acetamide dihydrochloride; N-(4-aminobutyl)acetamide hydrochloride; N-(5-aminopentyl)acetamide hydrochloride; N-acetylated; PUT; Polyamines; Prostate cancer; SPD; SPM; Urine; butane-1,4-diamine dihydrochloride; pentane-1,5-diamine dihydrochloride; propane-1,3-diamine dihydrochloride